The global elastography imaging market size reached USD 4,494.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 8,725.8 Million by 2033, exhibiting a growth rate (CAGR) of 6.89% during 2025-2033. The market is growing primarily because of ongoing developments in diagnostic procedures and the increasing need for minimally invasive imaging solutions. In addition, the increasing product applications in cardiology and oncology, escalating patient awareness about the benefits of early diagnosis, and rapid utilization of elastography imaging in hospitals are fueling the market growth.
Report Attribute
|
Key Statistics |
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 4,494.5 Million |
Market Forecast in 2033 | USD 8,725.8 Million |
Market Growth Rate (2025-2033) | 6.89% |
Advancements in Imaging Technology
The market is witnessing substantial growth due to rapid advancements in imaging technology, specially in techniques related to both shear and strain wave elastography. Such innovations provide better resolution and highly precise evaluation of tissue stiffness, which are critical in diagnosing disorders like breast lesions, liver fibrosis, and thyroid nodules. Consequently, surge in such diseases significantly spurs the innovations in imaging technology. According to a research article, liver diseases accounts for approximately 2 million deaths per year around the world. In addition, 4% of all global deaths result from a liver disease. Moreover, the integration of advanced technologies like machine learning and artificial intelligence is further improving diagnostic precision and workflow effectiveness. In addition, continuous enhancements in magnetic resonance and ultrasound elastography systems are proliferating their clinical uses, ultimately boosting heightened adoption in diagnostic centers and hospitals worldwide.
Increasing Product Demand for Non-Invasive Diagnostics
The global elastography imaging market is heavily benefitted from the increasing preference for non-invasive diagnostic solutions. Both healthcare providers are patients are rapidly substituting elastography over conventional biopsy techniques due to its capability to offer real-time evaluations without the requirement for invasive sampling of tissues. According to a research article published in May 2024, ultrasound elastography is the best and most accurate non-invasive imaging technology to monitor changes in tissue stiffness as well as elasticity. This shift is further bolstered by the need for less painful and time-saving diagnostics methods, specially for oncology and liver disorders. The non-invasive profile of elastography technique, coupled with its cost-efficiency and diagnostic accuracy, is propelling its adoption across numerous medical segments, further increasing market revenue.
Heightening Prevalence of Chronic Diseases
As per the elastography imaging market overview, the escalating incidents of chronic diseases like cardiovascular disorders, liver fibrosis, and cancer are substantially affecting the global market growth. According to the National Cancer Institute, by 2040, new cancer cases are projected to increase to 29.9 million annually, with an anticipated 15.3 million deaths. With the rapid growth of aging population and heightening prevalence of lifestyle-associated health disorders, there is an increasing demand for precise and early diagnostic solutions. Moreover, elastography imaging capability to assess and detect these diseases in early stages is crucial for efficient treatment strategy and regulation. Resultantly, healthcare providers are focusing on heavy investments in cutting-edge elastography devices to improve patient care, further spurring market expansion and fostering its pivotal role in modern medical imaging.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on modality, application, and end use.
Breakup by Modality:
Ultrasound accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the modality. This includes ultrasound and magnetic resonance. According to the report, ultrasound represented the largest segment.
According to the elastography imaging market forecast, ultrasound is anticipated to sustain the dominancy in this segment primarily due to its non-invasive profile, multi-functionality, and cost-efficiency. For instance, in June 2023, Mindray launched a Hepatus 6 Diagnostic Ultrasound System that is integrated with visual transient elastography technology and is particularly designed for non-invasive liver assessment. Ultrasound efficiently provides high-resolution and real-time imaging which establishes it as a preferred option for assessing certain soft tissues disorders, liver fibrosis, and breast cancer. Moreover, the escalating demand for innovations in elastography and early diagnosis, have further boosted adoption. In addition, portable ultrasound devices have expanded their reach to elastography, fostering its dominance in the global market.
Breakup by Application:
Radiology holds the largest share of the industry
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes radiology, cardiology, obstetrics, urology, vascular, orthopedic and musculoskeletal, and others. According to the report, radiology accounted for the largest market share.
Radiology represents the largest market share chiefly due to its crucial role in non-invasive diagnostics techniques. Various elastography techniques like shear and strain wave elastography, are rapidly being incorporated into radiological practices for monitoring and analyzing tissue stiffness, facilitating the early detection of chronic disorders such as musculoskeletal-related, tumors, and fibrosis. Furthermore, the demand for cutting-edge imaging techniques in radiology, significantly driven by the demand for real-time, precise, diagnostic solutions, substantially bolsters the utilization of elastography, fostering its leadership in this segment.
Breakup by End Use:
Hospital represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the end use. This includes hospitals, ambulatory surgery centers, and others. According to the report, hospitals represented the largest segment.
Hospitals accounts for the largest market share in the global elastography imaging market, principally due to their widespread utilization of innovative diagnostics techniques and abilities to manage high patient inflow. Furthermore, elastography imaging is essential for hospitals as it offers both precise and non-invasive monitoring of numerous conditions, such as breast cancer and liver fibrosis. Moreover, the rising prevalence of chronic diseases and the requirement for accurate diagnostics in a clinical environment further propel the demand for elastography technologies in hospitals, fortifying their market dominance.
Breakup by Region:
North America leads the market, accounting for the largest elastography imaging market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for elastography imaging.
North America is the largest regional market, primarily driven by increasing prevalence of chromic diseases like cancer, particularly in the United States, and an elevated adoption rate of high-tech diagnostics techniques. According to the National Institute of Cancer, 2,001,140 new cases of cancer are projected to be diagnosed in the United States in 2024, with an estimated 611,720 deaths. Moreover, the advanced healthcare infrastructure also contributes to the positive elastography imaging market outlook in the region by facilitating the employment of improved elastography-based medical devices. Furthermore, the region profits from substantial investments in R&D, stable healthcare expenditure, and a robust presence of major companies. In addition, rising awareness and requirement for non-invasive disease assessing methods further contribute to market expansion, establishing North America as a dominant region in the global market dynamics.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Modalities Covered | Ultrasound, Magnetic Resonance |
Applications Covered | Radiology, Cardiology, Obstetrics, Urology, Vascular, Orthopedic and Musculoskeletal, Others |
End Uses Covered | Hospitals, Ambulatory Surgery Centers, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Canon Medical Systems Corporation (Canon Inc.), Esaote SpA, Fujifilm Holdings Corporation, GE HealthCare, Hitachi, Ltd., Hologic, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG (Siemens AG), SonoScape Medical Corp, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |